Dr. Zinda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1104 John Nolen Dr
Madison, WI 53713Phone+1 608-251-6868Fax+1 608-251-4255
Education & Training
- Wake Forest University Baptist Medical CenterResidency, Radiation Oncology, 1980 - 1983
- Wake Forest University Baptist Medical CenterInternship, Internal Medicine, 1979 - 1980
- Medical College of WisconsinClass of 1979
Certifications & Licensure
- WI State Medical License 2001 - 2023
- OH State Medical License 1985 - 2019
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Publications & Presentations
PubMed
- 432 citationsThe JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid TumorsMichael Hedvat, Dennis Huszar, Andreas Herrmann, Joseph M. Gozgit, Anne Schroeder
Cancer Cell. 2009-12-08 - 108 citationsAZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic MalignanciesGarrett W. Rhyasen, Maureen Hattersley, Yi Yao, Austin Dulak, Wenxian Wang
Molecular Cancer Therapeutics. 2016-11-01 - 9 citationsNext-generation sequencing identifies a novel ELAVL1-TYK2 fusion gene in MOLM-16, an AML cell line highly sensitive to the PIM kinase inhibitor AZD1208.Adriana E. Tron, Erika Krasnickas Keeton, Minwei Ye, Matias Casás-Selves, Huawei Chen
Leukemia & Lymphoma. 2016-05-17
Press Mentions
- Repare Therapeutics to Highlight Program Progress for RP-6306 at Today’s Virtual Investor Day EventApril 8th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: